We are organising a pilot EQA scheme for molecular genetic analysis of EGFR in non-small cell lung cancer. We are delighted to offer this EQA as a collaboration between the EMQN, the European Society of Pathology (ESP), the European Thoracic Oncology Platform (ETOP) and the European Society of Medical Oncology (ESMO). The routine testing for EGFR mutations often involves individuals from both pathology and molecular genetic laboratories, as well as clinical colleagues, and therefore our collaboration reflects the nature of this interaction. We hope that the expertise from all three disciplines will help us provide a useful EQA pilot scheme.

If you are interested in participating in the pilot, please register via the scheme registration facility which is available to registered EMQN members. Please also note that registration does not guarantee participation in the pilot. Numbers are strictly limited and EMQN and its partners will decide which labs will participate to allow the best test of the scheme design. There is no fee for participation in the pilot.